MONCTON, NB, Sept. 14, 2018 CNW/ - Organigram Holdings Inc.
(TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram
Inc. (the "Company" or "Organigram"), a leading licensed producer
of medical marijuana, is pleased to announce that the Company has
signed a supply agreement with the Newfoundland and Labrador Liquor Corporation
(NLC) in anticipation of the launch of a legal, adult use
recreational cannabis market in the province.
"We are pleased to have been accepted as a supplier to NLC,"
says Greg Engel, Organigram's Chief
Executive Officer. "At Organigram, we are very proud of our
Atlantic Canadian roots and the opportunities we have to offer our
neighbours a broad choice of high-quality cannabis products."
According to the terms of the agreement, Newfoundland and Labrador cannabis retailers will have access
to almost 100% of Organigram's entire product portfolio. Organigram
will also play a role in the province's e-commerce plans, allowing
for consumers to order directly on-line.
"As we approach legalization, we look forward to working with
both the NLC and private retailers across the province to help
ensure the right tools are in place to offer consumers in
Newfoundland and Labrador an exceptional consumer experience,"
says Tim Emberg, Vice President of
Sales and Commercial Operations, Organigram.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing the highest-quality,
indoor-grown cannabis for patients and adult recreational consumers
in Canada, as well as developing
international business partnerships to extend the company's global
footprint. In anticipation of the legal adult use recreational
cannabis in Canada, Organigram has
developed a portfolio of brands including The Edison Cannabis
Company, Ankr Organics and Trailer Park Buds. Organigram's primary
facility is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the availability of
funds, consummation of definitive documentation, the results of
financing efforts, crop yields - that could cause actual results to
differ materially from the Company's expectations are disclosed in
the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
SOURCE OrganiGram